The first bellwether trials for reinstated Byetta, Victoza, pancreatitis lawsuits are not likely to begin before late 2020.…
A new study suggests Victoza works as a diabetes drug for children, but is linked to an increased risk of stomach problems.…
A growing number of lawsuits over claims that Byetta, Victoza and similar diabetes drugs can cause pancreatic cancer are being filed in the wake of a recent decision to reinstate the litigation.…
A new schedule for Byetta, Januvia and Victoza pancreatic cancer lawsuits sets the first bellwether trial for January 2020.…
A new study indicates that Invokana side effects may have some heart benefits, despite a growing number of adverse events linked to the diabetes drug.…
More than 700 Victoza, Byetta, Januvia and Janumet pancreatic cancer lawsuits have been reinstated by a federal appeals court, overturning a summary judgment that led to their dismissal in 2015.…
Difficulties in using the Tanzeum diabetes drug pen may be leading to medication mistakes and other adverse events, according to a new report.…
A proposed combination of Victoza and Tresiba is raising concerns among FDA reviewers who are worried that the low doses may expose patients to Victoza side effects without providing actual benefits.…
A federal judge has granted summary judgment in the federal litigation over incretin mimetic diabetes drugs, which alleged that inadequate warnings were provided about the risk of pancreatic cancer from Byetta, Victoza, Januvia and Janumet.…
Researchers who recently found that the active ingredient in Victoza and Saxenda could cause weight loss are now warning that their study also appeared to show signs of an association with gallbladder problems.…
